Methylation-associated silencing of microrna-126 and its host gene egfl7 in malignant pleural mesothelioma

Anticancer Research

Volumn 35, Issue 11, 2015, Pages 6223-6229

  Andersen, Morten ^a   Trapani, Davide ^a   Ravn, Jesper ^b   Sørensen, Jens Benn ^a   Andersen, Claus Bøgelund ^a   Grauslund, Morten ^a   Santoni Rugiu, Eric ^a  

^a Rigshospitalet   (Denmark)

^b Thoracic Surgery   (Denmark)

Author keywords

Biomarker; DNA methylation; EGFL7; Malignant pleural mesothelioma; MiR 126; Prognosis

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR LIKE PROTEIN 7; FORMALDEHYDE; MESSENGER RNA; MICRORNA 126; PARAFFIN; PEMETREXED; UNCLASSIFIED DRUG; EGFL7 PROTEIN, HUMAN; ENDOTHELIAL CELL GROWTH FACTOR; MICRORNA; MIRN126 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTRON; MALE; MESOTHELIUM CELL; PLEURA BIOPSY; PLEURA MESOTHELIOMA; PNEUMOTHORAX; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA METHYLATION; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; LUNG TUMOR; MESOTHELIOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PLEURA TUMOR; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; DNA METHYLATION; ENDOTHELIAL GROWTH FACTORS; EPIGENESIS, GENETIC; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; PROGNOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84946014558     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG: WHO classification of tumours of the lung, pleura, thymus and heart. Forth edition. Lyon, IARC Press, 2015.
2. Parker LH, Schmidt M, Jin S-W, Gray AM, Beis D, Pham T, Frantz G, Palmieri S, Hillan K, Stainier DYR, De Sauvage FJ and Ye W: The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 428: 754-758, 2004.
3. Schmidt M, Paes K, De Mazière A, Smyczek T, Yang S, Gray A, French D, Kasman I, Klumperman J, Rice DS and Ye W: EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Dev Camb Engl 134: 2913-2923, 2007.
4. Soncin F, Mattot V, Lionneton F, Spruyt N, Lepretre F, Begue A and Stehelin D: VE-statin, an endothelial repressor of smooth muscle cell migration. EMBO J 22: 5700-5711, 2003.
5. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
6. Sayed D and Abdellatif M: MicroRNAs in development and disease. Physiol Rev 91: 827-887, 2011.
7. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and Takahashi T: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005.
8. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
9. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D and Tang DG: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17: 211-215, 2011.
10. Musiyenko A, Bitko V and Barik S: Ectopic expression of miR-126, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. J Mol Med Berl Ger 86: 313-322, 2008.
11. Zhang J, Du Y, Lin Y, Chen Y, Yang L, Wang H and Ma D: The cell growth suppressor, miR-126, targets IRS-1. Biochem Biophys Res Commun 377: 136-140, 2008.
12. Sun Y, Bai Y, Zhang F, Wang Y, Guo Y and Guo L: miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun 391: 1483-1489, 2010.
13. Zhu N, Zhang D, Xie H, Zhou Z, Chen H, Hu T, Bai Y, Shen Y, Yuan W, Jing Q and Qin Y: Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol Cell Biochem 351: 157-164, 2011.
14. Jiao LR, Frampton AE, Jacob J, Pellegrino L, Krell J, Giamas G, Tsim N, Vlavianos P, Cohen P, Ahmad R, Keller A, Habib NA, Stebbing J and Castellano L: MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PloS One 7: e32068, 2012.
15. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC and Liang G: Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379: 726-731, 2009.
16. Feinberg AP, Ohlsson R and Henikoff S: The epigenetic progenitor origin of human cancer. Nat Rev Genet 7: 21-33, 2006.
17. Arai E and Kanai Y: DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status. Epigenomics 2: 467-481, 2010.
18. Andersen M, Grauslund M, Ravn J, Sørensen JB, Andersen CB and Santoni-Rugiu E: Diagnostic Potential of miR-126, miR-143, miR-145, and miR-652 in Malignant Pleural Mesothelioma. J Mol Diagn 16: 418-430, 2014.
19. Fan C, Yang L-Y, Wu F, Tao Y-M, Liu L-S, Zhang J-F, He Y-N, Tang L-L, Chen G-D and Guo L: The expression of Egfl7 in human normal tissues and epithelial tumors. Int J Biol Markers 28: 71-83, 2013.
20. Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y, Li C, Chong M, Ibrahim T, Mercatali L, Amadori D, Lu X, Xie D, Li Q-J and Wang X-F: miR-126 and miR-126repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 15: 284-294, 2013.
21. Santarelli L, Strafella E, Staffolani S, Amati M, Emanuelli M, Sartini D, Pozzi V, Carbonari D, Bracci M, Pignotti E, Mazzanti P, Sabbatini A, Ranaldi R, Gasparini S, Neuzil J and Tomasetti M: Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma. PloS One 6: e18232, 2011.
22. Tomasetti M, Nocchi L, Staffolani S, Manzella N, Amati M, Goodwin J, Kluckova K, Nguyen M, Strafella E, Bajzikova M, Peterka M, Lettlova S, Truksa J, Lee W, Dong L-F, Santarelli L and Neuzil J: MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function. Antioxid Redox Signal 21: 2109-2125, 2014.
23. Guo H, Ingolia NT, Weissman JS and Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840, 2010.
24. Li T, Li H, Wang Y, Harvard C, Tan J-L, Au A, Xu Z, Jablons DM and You L: The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma. J Pathol 223: 519-530, 2011.
25. Li Z, Li N, Wu M, Li X, Luo Z and Wang X: Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4. Mol Cell Biochem 381: 233-242, 2013.